BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keogh E, Mark Williams E. Managing malnutrition in COPD: A review. Respir Med 2021;176:106248. [PMID: 33253970 DOI: 10.1016/j.rmed.2020.106248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Pelgrim CE, van Ark I, van Berkum RE, Schuitemaker-borneman AM, Flier I, Leusink-muis T, Janbazacyabar H, Diks MAP, Gosker HR, Kelders MCJM, Langen RCJ, Schols AMWJ, Hageman RJJ, Braber S, Garssen J, Folkerts G, van Helvoort A, Kraneveld AD. Effects of a nutritional intervention on impaired behavior and cognitive function in an emphysematous murine model of COPD with endotoxin-induced lung inflammation. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1010989] [Reference Citation Analysis]
2 Shirai Y, Momosaki R, Kokura Y, Kato Y, Okugawa Y, Shimizu A. Validation of Asian Body Mass Index Cutoff Values for the Classification of Malnutrition Severity According to the Global Leadership Initiative on Malnutrition Criteria in Patients with Chronic Obstructive Pulmonary Disease Exacerbations. Nutrients 2022;14:4746. [DOI: 10.3390/nu14224746] [Reference Citation Analysis]
3 Rôlo Silvestre C, Dias Domingues T, Mateus L, Cavaco M, Nunes A, Cordeiro R, Silva Santos T, Falcão T, Domingos A, Santus P. The Nutritional Status of Chronic Obstructive Pulmonary Disease Exacerbators. Canadian Respiratory Journal 2022;2022:1-5. [DOI: 10.1155/2022/3101486] [Reference Citation Analysis]
4 Stephenson H, Roberts M, Klimkeit E, Smith T. Uncovering undernutrition in chronic obstructive pulmonary disease: Beyond body mass index. Respiratory Medicine 2022. [DOI: 10.1016/j.rmed.2022.107026] [Reference Citation Analysis]
5 Chen Z, Zha L, Ma X, Xu J, Huang D, Wu W, Chen L, Yang F, Liao W, Wang W. Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lung. [DOI: 10.1007/s00408-022-00568-5] [Reference Citation Analysis]
6 Stolz D, Mkorombindo T, Schumann DM, Agusti A, Ash SY, Bafadhel M, Bai C, Chalmers JD, Criner GJ, Dharmage SC, Franssen FME, Frey U, Han M, Hansel NN, Hawkins NM, Kalhan R, Konigshoff M, Ko FW, Parekh TM, Powell P, Rutten-van Mölken M, Simpson J, Sin DD, Song Y, Suki B, Troosters T, Washko GR, Welte T, Dransfield MT. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. The Lancet 2022;400:921-72. [DOI: 10.1016/s0140-6736(22)01273-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 García Castillo E, Alonso Pérez T, Peláez A, Pérez González P, Soriano JB, Ancochea J. . COPD 2022;Volume 17:2431-41. [DOI: 10.2147/copd.s377140] [Reference Citation Analysis]
8 Pyszora A, Lewko A. Non-pharmacological Management in Palliative Care for Patients With Advanced COPD. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.907664] [Reference Citation Analysis]
9 Soni N, Banerjee J, Gunasekaran V, Saini M, Singh V, Kumar P, Chakrawarty A, Chatterjee P, Dey AB. Association of geriatric syndromes in older adults with chronic obstructive pulmonary disease. Aging Medicine 2022;5:106-112. [DOI: 10.1002/agm2.12208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Huang D, Xie C, Sun C, Chen M, Li L, Yi H, Liao J, Zhao X, Shen X, He D, Li D, Wu D. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD 2022;Volume 17:781-9. [DOI: 10.2147/copd.s356314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kaluźniak-Szymanowska A, Krzymińska-Siemaszko R, Wieczorowska-Tobis K, Deskur-Śmielecka E. Optimal Assessment of Nutritional Status in Older Subjects with the Chronic Obstructive Pulmonary Disease-A Comparison of Three Screening Tools Used in the GLIM Diagnostic Algorithm. Int J Environ Res Public Health 2022;19:1025. [PMID: 35162048 DOI: 10.3390/ijerph19031025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Moitra S, Bandyopadhyay A, Lacy P. Metabolomics of Respiratory Diseases. Handbook of Experimental Pharmacology 2022. [DOI: 10.1007/164_2022_614] [Reference Citation Analysis]
13 Keogh E, Williams EM. Barriers to Prescribing Opioids in the Management of Chronic Breathlessness in COPD: A Review. COPD 2021;:1-10. [PMID: 34761726 DOI: 10.1080/15412555.2021.2000956] [Reference Citation Analysis]
14 Mancopes R, Borowsky da Rosa F, Tomasi LL, Pasqualoto AS, Steele CM. Chronic Obstructive Pulmonary Disease and Dysphagia: What Have We Learned So Far and What Do We Still Need to Investigate? Perspect ASHA SIGs 2021;6:1212-1221. [DOI: 10.1044/2021_persp-20-00288] [Reference Citation Analysis]
15 Xiang G, Zhu X, Ma L, Huang H, Wu X, Zhang W, Li S. Clinical guidelines on the application of Internet of Things (IOT) medical technology in the rehabilitation of chronic obstructive pulmonary disease. J Thorac Dis 2021;13:4629-37. [PMID: 34527304 DOI: 10.21037/jtd-21-670] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
16 Deng M, Yin Y, Zhang Q, Zhou X, Hou G. Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis. Front Immunol 2021;12:670971. [PMID: 34093570 DOI: 10.3389/fimmu.2021.670971] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]